• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的计算机疫苗设计。

In Silico Structure-Based Vaccine Design.

机构信息

Vaxine Pty Ltd, Adelaide, SA, Australia.

School of Pharmacy, University of Nottingham, Nottingham, UK.

出版信息

Methods Mol Biol. 2023;2673:371-399. doi: 10.1007/978-1-0716-3239-0_26.

DOI:10.1007/978-1-0716-3239-0_26
PMID:37258928
Abstract

Structure-based vaccine design (SBVD) is an important technique in computational vaccine design that uses structural information on a targeted protein to design novel vaccine candidates. This increasing ability to rapidly model structural information on proteins and antibodies has provided the scientific community with many new vaccine targets and novel opportunities for future vaccine discovery. This chapter provides a comprehensive overview of the status of in silico SBVD and discusses the current challenges and limitations. Key strategies in the field of SBVD are exemplified by a case study on design of COVID-19 vaccines targeting SARS-CoV-2 spike protein.

摘要

基于结构的疫苗设计(SBVD)是计算疫苗设计中的一项重要技术,它利用靶向蛋白的结构信息来设计新型疫苗候选物。这种快速建模蛋白质和抗体结构信息的能力为科学界提供了许多新的疫苗靶点和未来疫苗发现的新机会。本章全面概述了计算机辅助 SBVD 的现状,并讨论了当前的挑战和局限性。通过针对 SARS-CoV-2 刺突蛋白设计 COVID-19 疫苗的案例研究,举例说明了 SBVD 领域的关键策略。

相似文献

1
In Silico Structure-Based Vaccine Design.基于结构的计算机疫苗设计。
Methods Mol Biol. 2023;2673:371-399. doi: 10.1007/978-1-0716-3239-0_26.
2
Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An Analysis.基于 SARS-CoV-2 刺突蛋白的 COVID-19 多表位亚单位疫苗设计:分析。
J Immunol Res. 2020 Nov 19;2020:8893483. doi: 10.1155/2020/8893483. eCollection 2020.
3
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.基于深度学习的多表位疫苗设计:以 SARS-CoV-2 为例的研究。
Sci Rep. 2021 Feb 5;11(1):3238. doi: 10.1038/s41598-021-81749-9.
4
Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.基于结构的药物设计方法在新冠病毒刺突蛋白抑制剂设计中的应用
Curr Top Med Chem. 2022;22(29):2396-2409. doi: 10.2174/1568026623666221103091658.
5
Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.基于考虑表位变异性的共进化免疫信息学方法来对抗不同株:以 SARS-CoV-2 的刺突蛋白为例。
Comput Biol Med. 2023 Sep;163:107233. doi: 10.1016/j.compbiomed.2023.107233. Epub 2023 Jul 1.
6
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.基于反向疫苗学的 SARS-CoV-2 多表位亚单位疫苗设计。
Infect Dis Poverty. 2020 Sep 16;9(1):132. doi: 10.1186/s40249-020-00752-w.
7
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.针对 SARS-CoV-2 的 Spike 糖蛋白糖盾的一种多表位疫苗的合理设计。
J Biomol Struct Dyn. 2022 Sep;40(15):7099-7113. doi: 10.1080/07391102.2021.1894986. Epub 2021 Mar 10.
8
Design of multi-epitope vaccine candidate against SARS-CoV-2: a study.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的多表位候选疫苗设计:一项研究
J Biomol Struct Dyn. 2021 Jul;39(10):3793-3801. doi: 10.1080/07391102.2020.1770127. Epub 2020 Jun 1.
9
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.利用免疫信息学方法探索 SARS-CoV-2 的不可见抗原,设计候选多表位疫苗。
Vaccine. 2020 Nov 10;38(48):7612-7628. doi: 10.1016/j.vaccine.2020.10.016. Epub 2020 Oct 9.
10
design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein.基于 SARS-CoV-2 刺突蛋白的多表位肽疫苗的设计。
J Biomol Struct Dyn. 2022 Jul;40(11):5189-5202. doi: 10.1080/07391102.2020.1869092. Epub 2021 Jan 6.

本文引用的文献

1
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.SpikoGen®作为同源和异源加强疫苗的免疫原性和安全性:一项随机安慰剂对照试验。
Immunology. 2022 Nov;167(3):340-353. doi: 10.1111/imm.13540. Epub 2022 Jul 13.
2
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.康希诺-19/Spikogen® 疫苗基于重组刺突蛋白胞外域,与 Advax-CpG55.2 佐剂联合使用,可在仓鼠中提供针对 SARS-CoV-2 感染的单次剂量保护。
Vaccine. 2022 May 20;40(23):3182-3192. doi: 10.1016/j.vaccine.2022.04.041. Epub 2022 Apr 18.
3
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.SpikoGen®,一种 Advax-CpG55.2 佐剂的 SARS-CoV-2 刺突蛋白疫苗的安全性和免疫原性:在血清阳性和血清阴性人群中进行的 2 期随机安慰剂对照试验。
Clin Microbiol Infect. 2022 Sep;28(9):1263-1271. doi: 10.1016/j.cmi.2022.04.004. Epub 2022 Apr 15.
4
A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats.一种基于刺突蛋白的宠物用SARS-CoV-2亚单位疫苗:幼猫的安全性、免疫原性和保护效力
Front Vet Sci. 2022 Mar 14;9:815978. doi: 10.3389/fvets.2022.815978. eCollection 2022.
5
RCSB Protein Data Bank: Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D.RCSB 蛋白质数据库:用新工具庆祝 PDB 成立 50 周年,帮助理解和可视化 3D 生物大分子。
Protein Sci. 2022 Jan;31(1):187-208. doi: 10.1002/pro.4213. Epub 2021 Nov 6.
6
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.用 Advax-SM 佐剂配制的重组 SARS-CoV-2 刺突蛋白对雪貂和小鼠进行免疫接种可预防 COVID-19 感染。
Vaccine. 2021 Sep 24;39(40):5940-5953. doi: 10.1016/j.vaccine.2021.07.087. Epub 2021 Aug 3.
7
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.基于刺突糖蛋白的 SARS-CoV-2 疫苗及新病毒变异株的影响。
Front Immunol. 2021 Jul 12;12:701501. doi: 10.3389/fimmu.2021.701501. eCollection 2021.
8
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
9
In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.计算机模拟比较 SARS-CoV-2 刺突蛋白与 ACE2 的结合亲和力在不同物种间的差异及其对病毒起源的影响。
Sci Rep. 2021 Jun 24;11(1):13063. doi: 10.1038/s41598-021-92388-5.
10
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.SARS-CoV-2:结构、生物学和基于结构的治疗药物研发。
Front Cell Infect Microbiol. 2020 Nov 25;10:587269. doi: 10.3389/fcimb.2020.587269. eCollection 2020.